PRESOLICITATION NOTIFICATION UPDATE* This is an update from the previous Presolicitation Notice for W911QY-10-R-0027 for the NHRC Omnibus III ID/IQ. The Government intends to release the Final Request for Proposal within 45 days.
Added: Jun 03, 2010 4:05 pm The U. S. Army RDECOM Contracting, Natick Contracting Division on behalf of the U.S. Navy Medicine Research and Development (R&D) has a requirement for a (Omnibus III) contract to provide personnel and process infrastructure that will facilitate Navy Medicines mission to conduct Research & Development (R&D) across its enterprise, including commands that the Navy reports to or supports (e.g., OASD-Health Affairs, JTF CapMed, etc.). In addition to providing personnel, materials, equipment, and facilities (non-construction (bonded), non-Government spaces), this requirement addresses process infrastructure (such as basic university research, vaccine development, clinical trials, or FDA IND application processing). The mission of Navy Medicine is to provide high quality, economical health care to beneficiaries in wartime and in peacetime. Highly trained Navy Medicine personnel deploy with Sailors and Marines worldwide, providing critical mission support aboard ship, in the air, and on the battlefield. Additionally, Navy Medicines military and civilian health care professionals are providing care for uniformed services family members and retirees at military treatment facilities around the globe. Facility clearance may be required.The contract will be an Indefinite Delivery/Indefinite Quantity (ID/IQ) in which Task Orders may be issued and will be for a tee year base period and a two year option period. The Government envisions task orders which include the following contract types: Firm-Fixed-Price and Cost-Plus-Fixed-Fee. The guarantee minimum is anticipated to be $2,500.00 for the length of each task order (base year only) and the cumulative total of all Task Orders awarded to all awardees will not exceed $497,000,000 over the life of the contract. The Government envisions that multiple awards will be made; however, it reserves the right to make no award or to make a single award, if in the best interest of the Government. If for any reason, there are no successful proposals, or only one successful proposal, the Government reserves the right to re-open the solicitation. There will be two lots, a Full and Open and a partial Small Business set-aside. NAICS Code 541712, Research and Development in the Physical, Engineering and Life Sciences (except biotechnology), applies with a small business size standard of 500 Employees. The solicitation has been posted to the Natick Contracting Divisions website, located at https://www3.natick.army.mil (Select Current Acquisitions, then to the solicitation number). Proposals shall be due no later than 11:00 am on 2 August 2010. Any questions about this requirement must be submitted in writing to Lindsey Crockett at lindsey.crockett@us.army.mil. All proposals shall be sent to the address specified in the solicitation. Contracting Office Address: RDECOM Acquisition Center Natick Contracting Division, 13501 Ingenuity Drive, Ste 248, Orlando, FL 32826Place of Performance: Both intramural (on-site) and extramural (off-site) work will be performed. For intramural work, Government furnished spaces will be provided. No GFP is identified at this time for extramural work but may be specified at the task order level.Point of Contact(s): Brian Murphy (407) 384-5198RDECOM Acquisition Center - Natick W911QY-10-R-0027 Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground
6/3/10, 4:05 PM This effort includes: conducting extramural medical research or intramural (on-site) medical research performed by contractors; rapidly developing prototype infrastructure augmentations necessary to conduct such research.
Added: Jan 08, 2010 12:08 pm DescriptionSources Sought Notice (SSN) This is not a solicitation for bids/proposals but a SSN. This special notice synopsis is issued for the sole purpose of Navy Medicine to conduct Market Research in accordance with Federal Acquisition Regulation (FAR) Part 10.Navy Medicine Research & Development conducts research to enhance Navy Medicines operational readiness and performance when delivering health care. This effort is to provide comprehensive acquisition life cycle support services related to the American Warfighter as a weapon system in the context of Navy Medicine research. This includes (1) conducting extramural medical research or intramural (on-site) medical research performed by contractors or (2) rapidly developing prototype infrastructure augmentations necessary to conduct such research. The former includes medical research areas of interest such as: biological defense; infectious diseases; combat casualty care; dental and biomedical research; direct energy bioeffects; environmental health; aerospace medicine; undersea medicine; tropical medicine; marrow donor program; medical modeling, simulation, and mission support; warfighter performance; epidemiology and behavioral sciences; and special focus topics such as traumatic brain injury. The latter includes large-scale research infrastructure needs critical to Navy Medicines continued progress towards its strategic objectives and addresses enterprise or other major research services, capacities, processes (e.g., FDA IND), or facilities that meet the needs of Navy Medicine research efforts. This infrastructure could be focused on individual investigators or large groups of investigators or on disciplinary or multidisciplinary efforts. The infrastructure is intended to address the needs of researchers and scholars across the array of scholarly fields represented across Navy Medicine. Attempts to define what qualifies as research infrastructure will be imperfect and Navy Medicine will no doubt need to exercise judgment in evaluating the eligibility of individual submissions. Eligible examples may include: commercial processes (e.g., Contract Research Organizations), manufacturing (e.g., vaccine development), laboratories, major research equipment and technical staff support, repositories (e.g., tissue banking, genome repositories, artifact storage), high-end or unique computing needs (in consonance with Navy CIO direction), support staff/facilities for developing, using or maintaining equipment or laboratories, and research staff for consulting or other services (statistics, surveys, research/analysis design, biological computing). Examples not eligible are: new buildings or complete building renovations or infrastructure not related to research.Currently there are contract holders providing services under Omnibus 1 and 2. Omnibus 1 was specifically designed for medical research, but only for that portion of medical research necessary to complete the mission peculiar to the Naval Health Research Center (NHRC) and not all of Navy Medicine. Omnibus 2 was specifically designed for services in support of NHRC medical research such as fiscal and program management related services and not for all of Navy Medicine. Neither Omnibus 1 nor 2 addressed the Navy Medicine comprehensive extramural research requirement or the infrastructure necessary to sustain Navy Medicine research.Companies for profit, laboratories, joint ventures, vaccine manufacturers, Contract Research Organizations, non-profits, and universities are encouraged to respond. CCR registration is required for awards.ESTIMATED DOLLAR VALUE: $497 Million, as the ceiling for the entire contractACQUISITION APPROACH: The Government intends to make Multiple Awards Indefinite Delivery/Indefinite Quantity (ID/IQ) to a Full and Open Lot and a Partial Small Business Set-Aside Lot. Individual Task Orders will be competed amongst the ID/IQ awardees within the specific Lot. DISCLAIMER: This notice does not constitute an invitation for bids, or a Request for Proposal (RFP), and is not a commitment by the U.S. Government to procure subject services. RESPONSES REQUIRED: Interested offerors should provide a submission via email that includes a capabilities statement to the Contract Specialist by the closing date. Capabilities statements shall not exceed one (1) page and should outline the offerors ability to provide R&D services in the subject areas listed above. The submission must include a company name, address, telephone number, business size*, DUNS number, Federal CAGE Code, and point(s) of contact with an e-mail address, and a description of similar contracts. * Business size is the average monthly employee count over the last 12 months and the average annual gross revenue (in dollars) over the last tee complete accounting years (for all entities of the company, including parent and sibling organizations, independent of NAICS code).This SSN is not a commercial solicitation per FAR Part 12. Responses are due NLT 1700 EST, 18 Jan 2010Questions may be FAXed via 407-208-3401. No discussions will be conducted telephonically.Point of ContactMr. John Loper, Contract Specialist, 407-384-5569, john.loper2@us.army.mil or,Mr. Brian P. Murphy, Contracting officer, 407-384-5198, brian.murphy3@us.army.milPlace of PerformancePrimary: United States of AmericaSecondary: OCONUS locations as dictated in the resulting Task Orders W911QY-10-R-0027 Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground
1/8/10, 12:08 PM Omnibus III
Added: Apr 13, 2018 11:02 am This is a Class FAR Part 6 J&A to issue a modification to each of the Omnibus III Multiple-Award Task Order (MATO) Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts to extend the final ordering period from 30 March 2018 to 30 September 2018 and to increase the combined ceiling by $89M from $497M to $586M to allow the continuation of vital military medical research and development requirements. W911QY-10-R-0027 Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground
4/13/18, 11:02 AM Navy Medicine Omnibus III Multiple Award IDIQ Contract with a Full and Open Competition Lot and a Small Business Set-Aside Lot
Added: Aug 15, 2011 4:54 pm The U. S. Army ACC-APG, Natick Contracting Division on behalf of the U.S. Navy Medicine Research and Development (R&D) has a requirement for a Omnibus III contract to provide personnel and process infrastructure that will facilitate Navy Medicine's mission to conduct R&D across its enterprise, including commands that the Navy reports to or supports (e.g., OASD-Health Affairs, JTF CapMed, etc.). In addition to providing personnel, materials, equipment, and facilities (non-construction (bonded), non-Government spaces), this requirement addresses process infrastructure (such as basic university research, vaccine development, clinical trials, or FDA IND application processing). The mission of Navy Medicine is to provide high quality, economical health care to beneficiaries in wartime and in peacetime. Highly trained Navy Medicine personnel deploy with Sailors and Marines worldwide, providing critical mission support aboard ship, in the air, and on the battlefield. Additionally, Navy Medicine's military and civilian health care professionals are providing care for uniformed services' family members and retirees at military treatment facilities around the globe. W911QY-10-R-0027 Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground
8/15/11, 4:54 PM